Swiss Gender Medicine Symposium 2026: Translating Evidence Into Better Healthcare October 26–27, 2026 | Kursaal Bern, Switzerland

FemTech Capital is pleased to highlight the 2nd Swiss Gender Medicine Symposium, taking place on October 26–27, 2026, at Kursaal Bern.

The symposium will bring together researchers, clinicians, policymakers, public health experts and industry leaders from Switzerland and internationally to explore how scientific evidence on sex and gender can translate into better healthcare.

Featuring 40 international speakers, including Vera Regitz-Zagrosek, Noel Bairey Merz and Liisa Galea, the program combines scientific advances with practical approaches to implementation.

Key topics include:

* Women’s heart health and sex-specific medicine

* Sex and gender bias in artificial intelligence

* Clinical guidelines and medical education

* Patient involvement and prevention

* Global health policy and healthcare innovation

Through scientific sessions, keynote presentations, panels and practical discussions, the symposium aims to strengthen collaboration across research, clinical practice, policy and industry.

Why This Matters to FemTech Capital

Understanding biological sex differences and addressing gaps in medical research are essential to developing more effective, evidence-based healthcare.

At FemTech Capital, we believe advancing women’s health and sex-specific medicine requires stronger connections between scientific evidence, clinical expertise, innovation and capital.

We welcome initiatives that bring these communities together and help translate research into meaningful improvements in healthcare.

Event Details

Dates: October 26–27, 2026

Location: Kursaal Bern, Switzerland

Event: 2nd Swiss Gender Medicine Symposium

Registration and Program: https://www.swiss-gendermedicine.org/en

This is an independent ecosystem event highlighted by FemTech Capital. FTC is not the event organizer.

FemTech Capital | Science. Capital. Impact.

Advancing the Future of Women’s Health.